» Articles » PMID: 29567854

Risk Factors of Asthma Exacerbation Based on Asthma Severity: a Nationwide Population-based Observational Study in South Korea

Overview
Journal BMJ Open
Specialty General Medicine
Date 2018 Mar 24
PMID 29567854
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Asthma exacerbation, associated with many risks factors, can reflect management failure. However, little is known about how risk factors are associated with exacerbation, according to asthma severity. We aimed to investigate differences in risk factors in patients with different asthma severity and evaluate whether risk factors differed between frequent exacerbators and patients with single exacerbation.

Design: Nationwide population-based observational study.

Setting: Korean National Sample Cohort database.

Participants: We included 22 130 adults with asthma diagnoses more than twice (ICD-10 (International Classification of Diseases, Tenth revision) codes J45 and J46) and one prescription for asthma medication from 2010 to 2011.

Outcome Measures: Asthma exacerbation was defined as having a corticosteroid (CS) burst characterised by a prescription of high-dose oral CS for ≥3 days or one systemic CS injection, hospitalisation or emergency department visit.

Results: Among severities, history of CS bursts was significantly associated with exacerbation. In mild and moderate asthma, exacerbation was significantly associated with age ≥45 years, being female, gastro-oesophageal reflux disease and chronic rhinitis. High medication possession ratio (MPR≥50%), compared with low MPR (<20%) showed adjusted ORs of 0.828 (95% CI 0.707 to 0.971) and 0.362 (0.185 to 0.708) in moderate and severe asthma, respectively. In severe asthma, compared with mild asthma, only allergic rhinitis and history of hospitalisation were strongly associated with exacerbation. When comparing frequent exacerbators to patients with single exacerbation, age ≥45 years, atopic dermatitis, anxiety and history of CS burst were significant risk factors in mild and moderate asthma, whereas no risk factors were significant in severe asthma.

Conclusions: Different associations between risk factors and asthma exacerbations based on asthma severity suggest that patients with mild asthma require greater attention to their age and comorbidities, whereas those with severe asthma require greater attention to hospitalisation history and drug adherence.

Citing Articles

Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.

Ramirez G, Cardamone C, Lettieri S, Fredi M, Mormile I Clin Rev Allergy Immunol. 2025; 68(1):13.

PMID: 39932658 PMC: 11814061. DOI: 10.1007/s12016-024-09020-3.


Asthmatic patients with vitamin D deficiency: Can vitamin D supplementation make a difference.

Niu H, He H, Zhao Z, Lu X, Zhao G Technol Health Care. 2024; 32(6):3985-4008.

PMID: 39031398 PMC: 11612934. DOI: 10.3233/THC-231462.


Risk Factors for Acute Asthma Exacerbations in Adults With Mild Asthma.

Chen W, Puttock E, Schatz M, Crawford W, Vollmer W, Xie F J Allergy Clin Immunol Pract. 2024; 12(10):2705-2716.e6.

PMID: 38821437 PMC: 11464201. DOI: 10.1016/j.jaip.2024.05.034.


Incident Asthma, Asthma Exacerbations, and Asthma-Related Hospitalizations in Patients With Atopic Dermatitis.

Wan J, Wang S, Shin D, Syed M, Abuabara K, Lemeshow A J Allergy Clin Immunol Pract. 2023; 12(2):421-430.e1.

PMID: 37972919 PMC: 10922794. DOI: 10.1016/j.jaip.2023.11.009.


Adherence to treatment guidelines and good asthma control in Finland.

Pakkasela J, Salmela P, Juntunen P, Karjalainen J, Lehtimaki L Eur Clin Respir J. 2022; 10(1):2149918.

PMID: 36457457 PMC: 9707375. DOI: 10.1080/20018525.2022.2149918.


References
1.
Williams L, Peterson E, Wells K, Ahmedani B, Kumar R, Burchard E . Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011; 128(6):1185-1191.e2. PMC: 3229671. DOI: 10.1016/j.jaci.2011.09.011. View

2.
Lee Y, Kwon S, Hong S, Nam J, Song H, Lee J . Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database. Clin Ther. 2017; 39(3):527-536. DOI: 10.1016/j.clinthera.2017.01.025. View

3.
Yorke J, Fleming S, Shuldham C . Psychological interventions for adults with asthma. Cochrane Database Syst Rev. 2006; (1):CD002982. PMC: 7004249. DOI: 10.1002/14651858.CD002982.pub3. View

4.
Lee H, Rhee C, Lee B, Choi D, Kim J, Kim S . Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database. Int J Chron Obstruct Pulmon Dis. 2016; 11:775-83. PMC: 4841438. DOI: 10.2147/COPD.S95954. View

5.
McMahon A, Lipworth B, Davey P, Morris A, MacDonald T . Continuity of prescribing with inhaled corticosteroids and control of asthma. Pharmacoepidemiol Drug Saf. 2008; 9(4):293-303. DOI: 10.1002/1099-1557(200007/08)9:4<293::AID-PDS502>3.0.CO;2-S. View